Matthew H. Lyttle
15Patents
9h-index
11Co-inventors
61Inventor score
Filing activity: Sep 24, 1993 → Jul 10, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6013462A | Glutathione analogs as reagents | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5717085A | Process for preparing codon amidites | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5767086A | Bone marrow stimulation by certain glutathione analogs | Physics | 24 | Expired |
| US5556942A | Glutathione S-transferase-activated compounds | Physics | 24 | Expired |
| US5599903A | Glutathione analogs and paralog panels comprising glutathione mimics | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5955432A | Metabolic effects of certain glutathione analogs | Physics | 14 | Expired |
| US5763570A | Glutathione analogs and paralog panels comprising glutathione mimics | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5880097A | Tethered prodrugs | Human Necessities | 13 | Expired |
| US7029695B2 | Therapeutic compositions containing glutathione analogs | Human Necessities | 11 | Expired |
| US5545621A | Glutathione S-transferase-activated compounds | Physics | 7 | Expired |
| US5679643A | Glutathione analogs and paralog panels comprising glutathione mimics | Physics | 7 | Expired |
| US5688940A | Linker for immobilization, modification and subsequent release of oligomers with a terminal hydroxyl group | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5786336A | Target-selective protocols based on mimics | Physics | 6 | Expired |
| US5908919A | Urethane mediated, GST specific molecular release systems | Human Necessities | 3 | Expired |
| US5817758A | P-nitrobenzyl side-chain protection for solid-phase synthesis | Emerging Cross-Sectional Technologies | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.